FARE Blog

Guest post by Teen Advisory Group member Kate Stack

“Better safe than sorry!”, “It can’t be that bad, right?” and my personal favorite, “It doesn’t taste that good anyway!” are all things teens with food allergies hear on the daily. While there can be truth to some of these, it can be hard to manage the constant exclusion and deal with situations regarding your allergies.

When faced with the challenge of dining out with food allergies, Katie set out to find a solution. Her creativity and innovation led to My Teal Ticket, a restaurant order form that helps people with food allergies have a safer dining experience. Katie shares her story:

Last weekend, representatives from FARE attended a joint congress of the American Academy of Allergy, Asthma & Immunology (AAAAI) and the World Allergy Organization (WAO) in Orlando, FL.

In communities around the country, FARE supporters are doing their part to make the world safer for people with food allergies. Nine-year-old Lily proves that you’re never too young to get involved and make an impact. Her mother, Jaymie, shares Lily’s story:

This weekend, representatives from FARE are attending a joint congress of the American Academy of Allergy, Asthma & Immunology (AAAAI) and the World Allergy Organization (WAO) in Orlando, FL.

Red meat allergy – also called mammalian meat allergy or alpha-gal allergy – disrupts many of our food allergy assumptions.

Spring training is about to begin which means that summer is almost here! Attending a baseball game is a time honored tradition for many families each season. For individuals and families with peanut allergies, attending a game can be challenging.

Susie Hultquist is the food allergy mom behind Spokin, a mobile iOS app that puts food allergy resources in one place customized to your allergens, location and interests.

Two immunotherapy treatments for peanut allergy have completed Phase 3 clinical trials and are nearing submission for regulatory approval. If one or both of these therapies are approved by the Food and Drug Administration (FDA), standardized peanut allergy immunotherapy could become available as soon as next year.